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Abstract— Type 2 Diabetes screening and risk stratification 
tools could benefit from the incorporation of predictive sys-
tems based on computer modelling. The adoption of User 
Centered Design techniques is fundamental in order to inte-
grate these systems in an effective and successful way. The 
work presented in this paper describe the methodologies used 
in the context of a multidisciplinary research project and pro-
vides an overview of the preliminary results. 
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I. INTRODUCTION 
Type 2 Diabetes Mellitus (T2DM) is the most common 
form of diabetes. The World Health Organization estimates 
that by 2030 there will be about 550 million people suffer-
ing this disease [1.]. It is characterised by insulin resistance 
and relative insulin deficiency, either of which may be pre-
sent at the time that diabetes becomes clinically manifest. 
The diagnosis of type 2 diabetes usually occurs after the age 
of 40 or even earlier, especially in populations with high 
prevalence of this disease. It is often associated with obesi-
ty, which itself can cause insulin resistance and lead to 
elevated blood glucose levels [1.][2.]. This disease can re-
main undetected for many years because hyperglycemia 
develops gradually and at earlier stages is not severe enough 
for the patient to notice any of the classic symptoms of 
diabetes. Nevertheless, such patients are at increased risk of 
developing macrovascular (mainly stroke and acute coro-
nary syndromes) and microvascular (mainly retinopathy, 
neuropathy, nephropathy, and limb ischemia) complications 
and diagnosis is often made from associated complications 
or incidentally through an abnormal blood or urine glucose 
test. Risk prediction models (for both onset and evolution of 
the disease) have the potential to contribute to the 
healthcare interventions and decision-making processes, as 
recognized by the American Diabetes Association Consen-
sus Panel on September 2004 [3.]. However, despite the 
large number of models being developed and the increased 
interest and acknowledgement in the clinical field, only a 
very small minority ends-up being used in clinical practice.  
The main objective of the MOSAIC project is to develop 
a set of tools that will improve diagnosis, assessment and 
management of diabetes. These new tools are of technologi-
cal nature implementing a series of models and algorithms 
based on medical and scientific knowledge. One of the most 
important challenges of the project is to combine the re-
search activities related to the discovery of new risk factors, 
methods and models for diabetes onset, progression and 
evolution, with the integration of such risk factors, methods 
and models into software tools, components and modules 
that would incorporate these innovations and make them 
usable by different end-users in different settings and for 
different purposes. In other words, the challenge consists in 
transforming cutting-edge innovations in something that can 
make an impact the current clinical practice. Given the 
innovative potential of the MOSAIC solutions, we have to 
analyze in parallel: 
1. How the models can be transformed into Decision Sup-
port Systems (DSS) for T2DM management and detec-
tion (screening tools) 
2. Which are the indicators that could testify the success 
of the MOSAIC solutions 
3. Which are the requirements that the end-users would 
expect from these solutions 
For these reasons, the process that will lead to the devel-
opment and implementation of the system prototype, should 
involve users and stakeholders in the above analysis. If, 
from the functional and technical side, the requirements can 
be gathered by using traditional software engineering tech-
niques like Use Cases definition, other techniques are need-
ed to ensure that the developments will satisfy the needs of 
the final users and the goals to achieve for the target popula-
tion. The following 3 Use Cases (UCs) have been defined: 
1. UC1: Risk Factors and Indicators to improve current 
detection of T2DM.  
2. UC2: Hospital Care Management. 
3. UC3: Clinical Decision Support during follow-up visits. 
II. METHODS 
Given the multidisciplinary nature of this project and its 
challenges, and the need to find a balance on how much 
effort can be dedicated to the reiteration of the development 
phases, a holistic strategy is needed. In 2011, the Group 
from the University of Twente, published in an article called 
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“A Holistic Framework to Improve the Uptake and Impact 
of eHealth Technologies”, the CeHRes Roadmap [4.] 
¡Error! No se encuentra el origen de la referencia.. This 
roadmap was built as a result of a systematic review of 
existing eHealth frameworks, through which the authors 
gathered the most successful strategies and principles and at 
the same time, tried to overcome the limitations found. This 
framework is modular, it is based on a participatory devel-
opment approach, persuasive design techniques and busi-
ness modelling and serves as an evidence-based roadmap: it 
is thus suitable for the MOSAIC purposes and can be used 
to structure the different activities (research, development, 
business modelling, validation and evaluation) in a unified 
strategy. It is a dynamic framework and the authors have 
also published a wiki for collaborative use 
(http://ehealthwiki.org). 
 
Figure 1 - The CeHRes Roadmap (source: 
http://www.ehealthresearchcenter.org/wiki/) 
 
The CeHRes Roamap consists of five iterative phases, as 
shown in the figure. Even though there is a temporal execu-
tion of the different phases (from an idea to a product), the 
iterative nature of this roadmap, the modularity of the dif-
ferent methods and the feedback gathered through the form-
ative evaluation let the user of this method to adapt it to his 
or her specific needs. The authors provides some guidance 
on the research methods to be adopted for each case. Below, 
a brief description of the main methods we have chosen: 
? Contextual Inquiry 
Individual and Group Interviews: system users and/or 
experts discuss together or separately issues of use of the 
technical system to be developed. Usually, this is done, not 
only but especially, in the early phases of development, as 
this reveals which functionalities are more- or less desired, 
when they are desired and which emotional or organization-
al problems could be related to them. In the case of 
MOSAIC, focus groups already took place to discuss the 
values, attributes and requirements desired. Other focus 
groups and interviews have been planned, in order to collect 
some information that had been missing since the start of 
the project and to gather responses to some concise devel-
opment questions. This information would be used to pro-
duce a prototype which could then be tested by real users. 
? Value Specification 
Analytic Hierarchic Process (AHP), is a multi-
dimensional, multi-level and multifactorial decision-making 
method based on the idea that it is possible to prioritize 
elements by: grouping them into meaningful categories and 
sub-categories; performing pairwise comparison; defining a 
coherent framework of quantitative and qualitative 
knowledge; measuring intangible domains. This method has 
been applied to medical decision-making at hospital level 
for budget allocation, medical device purchasing and has 
the potential to be effective for different organizations and 
individuals interested in eliciting user requirements for 
example developers wishing to improve device design, 
hospital managers who must allocate budgets, clinical engi-
neers that are required to select devices. 
? Design Phase 
Heuristic analysis and development: usability heuris-
tics, guidelines and standardized design methodology are 
used in order to identify usability issues in the existing con-
cepts or prototypes of the respective module. As a result, the 
concept or prototype is refined.  
Cognitive walkthrough: this is another usability inspec-
tion method but, differently from the heuristic analysis, 
which takes a holistic view to catch problems, it is task-
specific, focusing on how easy it is for new users to perform 
the desired tasks. 
Usability Tests: this testing by users would be the final 
step in the usability engineering. Users would complete pre-
defined test tasks. Their behaviour would be recorded and 
their satisfaction measured with questionnaires. Thus, it 
would be possible to identify final potential for the im-
provement of the software prototypes. 
Supporting the final pilot tests: in this case, the main 
objective is to analyse the performance of the system in 
terms of uptake and impact potential. In the first case, the 
usage behaviour, the user profile and motivations are as-
sessed, while for the second case, we will look at the impact 
on healthcare delivery (e.g. efficiency, safety, interaction, 
etc.) outcomes. 
III. THE MOSAIC USER CENTERED DESIGN STRATEGY  
In order to define and develop the User Interface (UI) 
and Interaction Flows of the MOSAIC system, 4 elements 
are taken into account: 
? The priority assigned to the different values-attributes-
requirements, to understand the aspects that need to be 
tackled most. 
? The content, the input and the output of each UI 
? The Interaction Flows 
? The Components of each UI 
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? The target population of patients (people at risk of 
T2DM, early T2Dm, T2DM). 
All these components will need the involvement of end-
users and stakeholders for their definition and validation. 
The following steps will be executed for the definition 
and development of the 3 UCs. 
1. The initial starting point was the MOSAIC Grant and 
the first research activities, where all the modelling 
techniques, data sources and clinical and technical 
specifications have been analyzed. 
2. Several focus groups where carried out through virtual 
and physical meetings, as well as informal communica-
tions via email, leading to the definition of the main 
three Use Cases.  
3. After that, a low level mock-up (wire framing) is built. 
This mock-up is evaluated internally and after some it-
erations a final low level mock-up has been created. 
4. Values, attributes and requirements, already extracted 
through focus groups and workshops, are ranked 
through the AHP, in order to validate and prioritize the 
key issues identified so far, resulting in a reinforced us-
er need elicitation. 
5. The requirements, are used to create mock-ups and 
questionnaires that will be validated through focus 
groups and/or individual interviews, in order to refine 
the prototype development. 
6. Heuristic analysis. The Heuristic Evaluation is carried 
out, consisting of a session with 4-5 usability experts 
following the recommendations of the 10 Nielsen Heu-
ristics. 
7. The 1st Prototype is analyzed by the consortium part-
ners and then is presented to a small group of experts. 
8. The prototype will be analysed through walkthrough 
and usability tests with end-users. 
9. Depending on the above results, the most relevant 
methods, among the ones described in this manuscript, 
will be adopted to support the development of the 2nd 
and final prototype. 
IV. RESULTS 
A first iteration has been almost completed (the first 6 
points have been executed). We hereby describe the prelim-
inary results coming from the user needs elicitation, heuris-
tic evaluation and concept validation of the first versions of 
the mockups for each UC. 
A. Analytic Hierarchy Process 
The following three of needs (or hierarchy) have been creat-
ed and agreed with the AHP expert and modelling partners. 
 
 
Figure 2 Hierarchy of needs for the development of the 
MOSAIC Tools 
 
This hierarchy is being currently evaluated by 3 groups of 
experts (1 for each Use Case), among the partners of the 
consortium. By performing pairwise comparisons, the re-
sponders are asked to evaluate which are the most important 
factors to take into account for developing the tools corre-
sponding to the three main Use Cases. The main questions, 
for each of them, are the following: 
1. In a technological solution for T2DM screening, … 
2. In a technological solution that support you in per-
forming risk stratification on the T2DM population of 
your clinical department/hospital… 
3. In a technological solution that support you in under-
standing the clinical evolution of your patient... 
… and from your point of view and according to your 
experience, which is the most important element and 
how much important it is, with respect to the other one 
(from 1, equally important to 9 much more important)? 
To date, two (2) experts have answered to UC1, six (6) to 
UC2 and three (3) to UC3: 
? As regards T2DM screening (UC1), MOSAIC should 
let improve access in health care delivery, that is, pro-
vide a better access to data that are already there but not 
exploited.  
? In the case of the risk stratification for hospital man-
agement (UC2), the responders give more importance 
to increase the support to decision, in particular to min-
imize false negatives.  
? Finally, regarding the support during follow up visits 
(UC3), users are more interested to increase the effi-
ciency of the health care delivery, with a clear interest 
in the cost-efficient output component.  
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Of course these are preliminary results but it is already 
interesting to highlight how the same factors are considered 
differently for the three UCs. 
B. User Interfaces Definition and Validation 
In this case, given the difficulties in organizing a focus 
group, it was decided and agreed to validate the interfaces 
via online questionnaires. These have been created through 
Google form. For each UC, a description of the application, 
pictures of the User Interfaces and a video showing the 
interaction flow have been included. 
The same groups and numbers of users answering the AHP 
questionnaires have been identified for this validation. So 
far, two (2) experts have answered to UC1, six (6) to UC2 
and three (3) to UC3. 
In the case of UC1, the main comments are that the tools 
can be very useful for the working activities of the users, for 
arranging daily routines. As regards the frequency of use, 
they suggest to be not on a daily basis or on (“I would close 
my week in doing 1 hour in the office dedicated with 
MOSAIC”). Visualizing the path from basic data to recom-
mendation has been required too. 
In the case of UC2, the comments about the usefulness of 
the tools and of the clarity of the information provided are 
also above the acceptance threshold. Some general charts 
should be improved in terms of clarity and of relevant in-
formation (i.e.: add “cost-opportunity drugs”); the tool 
should be visualized by all the members of the care team, in 
order to improve the decision making process. 
Finally, for UC3, even though the usefulness and the poten-
tial use in clinical practice has been positively rated, users 
asked to improve the workflow (the evaluation was rated 
below the acceptance threshold). The decisions they would 
like to be assisted most are related to the antidiabetic drug 
prescriptions (patient categorization based on risk of com-
plications) and to the management of both comorbidities 
and complications. 
C. Heuristic Evaluation of the Interfaces 
The Heuristic Evaluation was carried out by 8 usability 
experts, to which the same videos and images resources 
generated previously have been sent. The evaluation is 
composed of two phases: during the first one, all the re-
sponders are asked to carry out a classic Heuristic Evalua-
tion taking into account the Nielsen's Heuristic as reference 
of the evaluation; in the second one, all the results are 
merged and this integrated version is sent back to the evalu-
ators who are asked to rate each issue from 0 (not an usabil-
ity issue) to 4 (very important usability issue).  
The results are being used to refine and redefine the inter-
faces and the interaction flow. 
Briefly, the first prototype failed to show clearly the differ-
ent steps that the users has to fill in in order to achieve a 
successful outcome, i.e. the approach used in the mock-up 
based on tabs was not easy to understand for most of the 
users, instead most of them suggested to use a simple inter-
face showing the number of steps and current step where the 
user is. 
To summarize, the most severe issues regarding the usabil-
ity were: 1) a severe lack of visibility of system status, es-
pecially regarding the different steps that the user has to go 
through to achieve a correct outcome, 2) according to most 
of the experts the match between system and the real world 
should be improved (this involves the employment of a 
interface closer to the clinical world, both in the written 
text, icons and so on), 3) a common complaint is that this 
mock-up did not handle the error prevention, i.e. it did not 
show how the system would behave in case any error or 
unexpected behavior happens and finally 4) the system 
should include more help, documentation and guide the 
users about how to proceed on each situation according to 
the experts. 
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